Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Mar;75(3):1037–1044. doi: 10.1172/JCI111765

Role of parathyroid hormone in the glucose intolerance of chronic renal failure.

M Akmal, S G Massry, D A Goldstein, P Fanti, A Weisz, R A DeFronzo
PMCID: PMC423657  PMID: 3884663

Abstract

Evidence has accumulated suggesting that the state of secondary hyperparathyroidism and the elevated blood levels of parathyroid hormone (PTH) in uremia participate in the genesis of many uremic manifestations. The present study examined the role of PTH in glucose intolerance of chronic renal failure (CRF). Intravenous glucose tolerance tests (IVGTT) and euglycemic and hyperglycemic clamp studies were performed in dogs with CRF with (NPX) and without parathyroid glands (NPX-PTX). There were no significant differences among the plasma concentrations of electrolytes, degree of CRF, and its duration. The serum levels of PTH were elevated in NPX and undetectable in NPX-PTX. The NPX dogs displayed glucose intolerance after CRF and blood glucose concentrations during IVGTT were significantly (P less than 0.01) higher than corresponding values before CRF. In contrast, blood glucose levels after IVGTT in NPX-PTX before and after CRF were not different. K-g rate fell after CRF from 2.86 +/- 0.48 to 1.23 +/- 0.18%/min (P less than 0.01) in NPX but remained unchanged in NPX-PTX (from 2.41 +/- 0.43 to 2.86 +/- 0.86%/min) dogs. Blood insulin levels after IVGTT in NPX-PTX were more than twice higher than in NPX animals (P less than 0.01) and for any given level of blood glucose concentration, the insulin levels were higher in NPX-PTX than NPX dogs. Clamp studies showed that the total amount of glucose utilized was significantly lower (P less than 0.025) in NPX (6.64 +/- 1.13 mg/kg X min) than in NPX-PTX (10.74 +/- 1.1 mg/kg X min) dogs. The early, late, and total insulin responses were significantly (P less than 0.025) greater in the NPX-PTX than NPX animals. The values for the total response were 143 +/- 28 vs. 71 +/- 10 microU/ml, P less than 0.01. There was no significant difference in the ratio of glucose metabolized to the total insulin response, a measure of tissue sensitivity to insulin, between the two groups. The glucose metabolized to total insulin response ratio in NPX (5.12 +/- 0.76 mg/kg X min per microU/ml) and NPX-PTX (5.18 +/- 0.57 mg/kg X min per microU/ml) dogs was not different but significantly (P less than 0.01) lower than in normal animals (9.98 +/- 1.26 mg/kg X min per microU/ml). The metabolic clearance rate of insulin was significantly (P less than 0.02) reduced in both NPX (12.1 +/- 0.7 ml/kg X min) and NPX-PTX (12.1 +/- 0.9 ml/kg X min) dogs, as compared with normal animals (17.4 +/- 1.8 ml/kg X min). The basal hepatic glucose production was similar in both groups of animals and nor different from normal dogs; both the time course and the magnitude of suppression of hepatic glucose production by insulin were similar in both in groups. There were no differences in the binding affinity, binding sites concentration, and binding capacity of monocytes to insulin among NPX, NPX-PTX, and normal dogs. The data show that (a) glucose intolerance does not develop with CRF in the absence of PTH, (b) PTH does not affect metabolic clearance of insulin or tissue resistance to insulin in CRF, and (c) the normalization of metabolism in CRF in the absence of PTH is due to increased insulin secretion. The results indicate that excess PTH in CRF interferes with the ability of the beta-cells to augment insulin secretion appropriately in response to the insulin-resistant state.

Full text

PDF
1037

Images in this article

1041Image
on p.1041
1041Image
on p.1041
1041Image
on p.1041
1041Image
on p.1041
1041Image
on p.1041
1041Image
on p.1041
1041Image
on p.1041

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amend W. J., Jr, Steinberg S. M., Lowrie E. G., Lazarus J. M., Soeldner J. S., Hampers C. L., Merrill J. P. The influence of serum calcium and parathyroid hormone upon glucose metabolism in uremia. J Lab Clin Med. 1975 Sep;86(3):435–444. [PubMed] [Google Scholar]
  2. Arieff A. I., Massry S. G. Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone. J Clin Invest. 1974 Feb;53(2):387–392. doi: 10.1172/JCI107571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Avram M. M., Feinfeld D. A., Huatuco A. H. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia. N Engl J Med. 1978 May 4;298(18):1000–1003. doi: 10.1056/NEJM197805042981805. [DOI] [PubMed] [Google Scholar]
  4. Beck-Nielsen H., Pedersen O., Kragballe K., Sorensen N. S. The monocyte as a model for the study of insulin receptors in man. Diabetologia. 1977 Dec;13(6):563–569. doi: 10.1007/BF01236308. [DOI] [PubMed] [Google Scholar]
  5. Beck P., Schalch D. S., Parker M. L., Kipnis D. M., Daughaday W. H. Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly. J Lab Clin Med. 1965 Sep;66(3):366–379. [PubMed] [Google Scholar]
  6. Berson S. A., Yalow R. S. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. Science. 1966 Nov 18;154(3751):907–909. doi: 10.1126/science.154.3751.907. [DOI] [PubMed] [Google Scholar]
  7. Bevilacqua S., Barrett E., Ferrannini E., Gusberg R., Stewart A., Richardson L., Smith D., DeFronzo R. Lack of effect of parathyroid hormone on hepatic glucose metabolism in the dog. Metabolism. 1981 May;30(5):469–475. doi: 10.1016/0026-0495(81)90182-7. [DOI] [PubMed] [Google Scholar]
  8. Bogin E., Massry S. G., Harary I. Effect of parathyroid hormone on rat heart cells. J Clin Invest. 1981 Apr;67(4):1215–1227. doi: 10.1172/JCI110137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bogin E., Massry S. G., Levi J., Djaldeti M., Bristol G., Smith J. Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest. 1982 Apr;69(4):1017–1025. doi: 10.1172/JCI110505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Borle A. B. Calcium metabolism at the cellular level. Fed Proc. 1973 Sep;32(9):1944–1950. [PubMed] [Google Scholar]
  11. Chausmer A. B., Sherman B. S., Wallach S. The effect of parathyroid hormone on hepatic cell transport of calcium. Endocrinology. 1972 Mar;90(3):663–672. doi: 10.1210/endo-90-3-663. [DOI] [PubMed] [Google Scholar]
  12. De Meyts P., Roth J. Cooperativity in ligand binding: a new graphic analysis. Biochem Biophys Res Commun. 1975 Oct 27;66(4):1118–1126. doi: 10.1016/0006-291x(75)90473-8. [DOI] [PubMed] [Google Scholar]
  13. DeFronzo R. A., Alvestrand A., Smith D., Hendler R., Hendler E., Wahren J. Insulin resistance in uremia. J Clin Invest. 1981 Feb;67(2):563–568. doi: 10.1172/JCI110067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. DeFronzo R. A., Andres R., Edgar P., Walker W. G. Carbohydrate metabolism in uremia: a review. Medicine (Baltimore) 1973 Sep;52(5):469–481. doi: 10.1097/00005792-197309000-00009. [DOI] [PubMed] [Google Scholar]
  15. DeFronzo R. A. Pathogenesis of glucose intolerance in uremia. Metabolism. 1978 Dec;27(12 Suppl 2):1866–1880. doi: 10.1016/s0026-0495(78)80005-5. [DOI] [PubMed] [Google Scholar]
  16. DeFronzo R. A., Soman V., Sherwin R. S., Hendler R., Felig P. Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest. 1978 Jul;62(1):204–213. doi: 10.1172/JCI109108. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  17. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  18. DeFronzo R. A., Tobin J. D., Rowe J. W., Andres R. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest. 1978 Aug;62(2):425–435. doi: 10.1172/JCI109144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Drüeke T., Fauchet M., Fleury J., Lesourd P., Toure Y., Le Pailleur C., de Vernejoul P., Crosnier J. Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet. 1980 Jan 19;1(8160):112–114. doi: 10.1016/s0140-6736(80)90602-9. [DOI] [PubMed] [Google Scholar]
  20. GARDNER L. I., TALBOT N. B., COOK C. D., BERMAN H., URIBE R. C. The effect of potassium deficiency on carbohydrate metabolism. J Lab Clin Med. 1950 Apr;35(4):592–602. [PubMed] [Google Scholar]
  21. Gerich J. E., Charles M. A., Grodsky G. M. Regulation of pancreatic insulin and glucagon secretion. Annu Rev Physiol. 1976;38:353–388. doi: 10.1146/annurev.ph.38.030176.002033. [DOI] [PubMed] [Google Scholar]
  22. Ginsberg H., Olefsky J. M., Reaven G. M. Evaluation of insulin resistance in patients with primary hyperparathyroidism. Proc Soc Exp Biol Med. 1975 Mar;148(3):942–945. doi: 10.3181/00379727-148-38665. [DOI] [PubMed] [Google Scholar]
  23. Goldstein D. A., Chui L. A., Massry S. G. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J Clin Invest. 1978 Jul;62(1):88–93. doi: 10.1172/JCI109118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Goldstein D. A., Feinstein E. I., Chui L. A., Pattabhiraman R., Massry S. G. The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients. J Clin Endocrinol Metab. 1980 Jul;51(1):130–134. doi: 10.1210/jcem-51-1-130. [DOI] [PubMed] [Google Scholar]
  25. Guisado R., Arieff A. I., Massry S. G., Lazarowitz V., Kerian A. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J Clin Invest. 1975 Apr;55(4):738–745. doi: 10.1172/JCI107984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hampers C. L., Soeldner J. S., Doak P. B., Merrill J. P. Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest. 1966 Nov;45(11):1719–1731. doi: 10.1172/JCI105478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hedeskov C. J. Mechanism of glucose-induced insulin secretion. Physiol Rev. 1980 Apr;60(2):442–509. doi: 10.1152/physrev.1980.60.2.442. [DOI] [PubMed] [Google Scholar]
  28. Hems D. A., Harmon C. S., Whitton P. D. Inhibition by parathyroid hormone of glycogen synthesis in the perfused rat liver. FEBS Lett. 1975 Oct 15;58(1):167–169. doi: 10.1016/0014-5793(75)80250-x. [DOI] [PubMed] [Google Scholar]
  29. Hruska K. A., Blondin J., Bass R., Santiago J., Thomas L., Altsheler P., Martin K., Klahr S. Effect of intact parathyroid hormone on hepatic glucose release in the dog. J Clin Invest. 1979 Oct;64(4):1016–1023. doi: 10.1172/JCI109538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kahil M. E., Parrish J. E., Simons E. L., Brown H. Magnesium deficiency and carbohydrate metabolism. Diabetes. 1966 Oct;15(10):734–739. doi: 10.2337/diab.15.10.734. [DOI] [PubMed] [Google Scholar]
  31. Kanatsuka A., Makino H., Matsushima Y., Kasanuki J., Osegawa M., Kumagai A. Effect of calcium on the secretion of somatostatin and insulin from pancreatic islets. Endocrinology. 1981 Jun;108(6):2254–2257. doi: 10.1210/endo-108-6-2254. [DOI] [PubMed] [Google Scholar]
  32. Kim H., Kalkhoff R. K., Costrini N. V., Cerletty J. M., Jacobson M. Plasma insulin disturbances in primary hyperparathyroidism. J Clin Invest. 1971 Dec;50(12):2596–2605. doi: 10.1172/JCI106760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. LUNDBAEK K. Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Br Med J. 1962 Jun 2;1(5291):1507–1513. doi: 10.1136/bmj.1.5291.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lindall A., Carmena R., Cohen S., Comty C. Insulin hypersecretion in patients on chronic hemodialysis. Role of parathyroids. J Clin Endocrinol Metab. 1971 May;32(5):653–658. doi: 10.1210/jcem-32-5-653. [DOI] [PubMed] [Google Scholar]
  35. Littledike E. T., Witzel D. A., Whipp S. C. Insulin: evidence for inhibition of release in spontaneous hypocalcemia. Proc Soc Exp Biol Med. 1968 Oct;129(1):135–139. doi: 10.3181/00379727-129-33269. [DOI] [PubMed] [Google Scholar]
  36. Lowrie E. G., Soeldner J. S., Hampers C. L., Merrill J. P. Glucose metabolism and insulin secretion in uremic, prediabetic, and normal subjects. J Lab Clin Med. 1970 Oct;76(4):603–615. [PubMed] [Google Scholar]
  37. Meytes D., Bogin E., Ma A., Dukes P. P., Massry S. G. Effect of parathyroid hormone on erythropoiesis. J Clin Invest. 1981 May;67(5):1263–1269. doi: 10.1172/JCI110154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  39. Mondon C. E., Dolkas C. B., Reaven G. M. The site of insulin resistance in acute uremia. Diabetes. 1978 May;27(5):571–576. doi: 10.2337/diab.27.5.571. [DOI] [PubMed] [Google Scholar]
  40. Moxley M. A., Bell N. H., Wagle S. R., Allen D. O., Ashmore J. Parathyroid hormone stimulation of glucose and urea production in isolated liver cells. Am J Physiol. 1974 Nov;227(5):1058–1061. doi: 10.1152/ajplegacy.1974.227.5.1058. [DOI] [PubMed] [Google Scholar]
  41. Perley M., Kipnis D. M. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes. 1966 Dec;15(12):867–874. doi: 10.2337/diab.15.12.867. [DOI] [PubMed] [Google Scholar]
  42. Roth S. I., Marshall R. B. Pathology and ultrastructure of the human parathyroid glands in chronic renal failure. Arch Intern Med. 1969 Oct;124(4):397–407. [PubMed] [Google Scholar]
  43. Samaan N. A., Freeman R. M. Growth hormone levels in severe renal failure. Metabolism. 1970 Feb;19(2):102–113. [PubMed] [Google Scholar]
  44. WESTERVELT F. B., Jr, SCHREINER G. E. The carbohydrate intolerance of uremic patients. Ann Intern Med. 1962 Aug;57:266–276. doi: 10.7326/0003-4819-57-2-266. [DOI] [PubMed] [Google Scholar]
  45. Yasuda K., Hurukawa Y., Okuyama M., Kikuchi M., Yoshinaga K. Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release. N Engl J Med. 1975 Mar 6;292(10):501–504. doi: 10.1056/NEJM197503062921003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES